16S rRNA sequencing of gut microbiome in PH-PS treated mice

Exploratory Score: 0.800 Price: $0.50 Alzheimer's disease 5×FAD transgenic mice Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting 16S rRNA in 5×FAD transgenic mice. Primary outcome: gut microbiome composition changes

Description

This experiment specifically focused on analyzing the gut microbiome changes induced by PH-PS treatment using 16S rRNA gene sequencing. The study examined the intestinal flora composition in 5×FAD mice before and after PH-PS treatment to understand how the polysaccharide modulates gut bacteria populations. The sequencing analysis revealed that PH-PS treatment promoted beneficial probiotic microbiota including Lactobacillus, Muribaculum, Monoglobus, and [Eubacterium]_siraeum_group, while simultaneously suppressing inflammation-related bacteria such as UCG-009 and Blautia. This microbiome remodeling was linked to the restoration of intestinal barrier function and reduction of peripheral inflammation. The experiment provided crucial evidence for the gut-brain axis mechanism underlying PH-PS neuroprotective effects, demonstrating that dietary polysaccharides can influence brain health through modulation of the intestinal microbiome.

TARGET GENE
16S rRNA
MODEL SYSTEM
5×FAD transgenic mice
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
gut-brain axis, intestinal barrier function
SOURCE
extracted_from_pmid_38750854
PRIMARY OUTCOME
gut microbiome composition changes

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.800 composite

📖 Wiki Pages

Agitation in Alzheimer's DiseasediseaseAlzheimer's DiseasediseaseAlzheimer's DiseasediseaseAlzheimer's Disease Genetic VariantsdiseaseAlzheimer's Disease vs Parkinson's Disease ComparidiseaseAPP Mutations in Alzheimer's DiseasediseaseDLB, Parkinson's Disease, and Alzheimer's Disease:diseaseEarly-Onset Alzheimer's Disease (EOAD)diseaseInvestment Landscape: Alzheimer's DiseasediseasePreclinical Alzheimer's DiseasediseaseProdromal Alzheimer's DiseasediseasePSEN1 Mutations in Alzheimer's DiseasediseasePSEN2 Mutations in Alzheimer's DiseasediseaseSporadic vs Familial Alzheimer's Disease: ComprehediseaseTREM2 Variants in Alzheimer's Diseasedisease

Protocol

16S rRNA gene sequencing, bioinformatics analysis of bacterial taxa, correlation analysis with neuroinflammatory markers

Expected Outcomes

Increased beneficial bacteria, decreased harmful bacteria, improved gut barrier function

Success Criteria

Promotion of probiotic microbiota (Lactobacillus, Muribaculum, Monoglobus, [Eubacterium]_siraeum_group) and suppression of inflammation-related bacteria (UCG-009, Blautia)

Related Hypotheses (5)

TREM2-mediated microglial tau clearance enhancement0.800
HSP90-Tau Disaggregation Complex Enhancement0.752
LRP1-Dependent Tau Uptake Disruption0.747
VCP-Mediated Autophagy Enhancement0.713
Extracellular Vesicle Biogenesis Modulation0.635

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.